C(OC([N:8]1[CH2:13][CH2:12][C:11]2[NH:14][N:15]=[C:16]([C:17]3[NH:21][C:20]4[CH:22]=[C:23]([CH3:27])[C:24]([CH3:26])=[CH:25][C:19]=4[N:18]=3)[C:10]=2[CH2:9]1)=O)(C)(C)C.Cl>CO.O1CCOCC1>[CH3:26][C:24]1[C:23]([CH3:27])=[CH:22][C:20]2[NH:21][C:17]([C:16]3[C:10]4[CH2:9][NH:8][CH2:13][CH2:12][C:11]=4[NH:14][N:15]=3)=[N:18][C:19]=2[CH:25]=1A solution of 3-(5,6-dimethyl-1H-benzoimidazol-2-yl)-1,4,6,7-tetrahydro-pyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester [1.014 g, Example 252(a)] in methanol (20 ml) was treated with a solution of hydrogen chloride in dioxane (5 ml, 4M). After stirring for 16 hours the reaction mixture was evaporated. The resulting beige solid was triturated with methanol to yield 3-(5,6-dimethyl-1H-benzoimidazol-2-yl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine (0.523 g) as a pale yellow solid. LC-MS (METHOD B): RT=0.63 minutes; 268 (M+H)+. (b) 3-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine
Loading…
